A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphomaAndrew Looka, Caron A. Jacobson, Caitlyn Duffy et al.|Blood Advances|2024Cited by 30
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy RecipientsMuneerah M Aleissa, Amy C Sherman, Jessica S Little et al.|Transplantation and Cellular Therapy|2023Cited by 15